Results 221 to 230 of about 52,456 (284)
Some of the next articles are maybe not open access.
New England Journal of Medicine, 1978
Twenty-two smokers with elevated hematocrits (mean, 54 per cent) had elevated blood carboxyhemoglobin (mean, 11.6 per cent; normal, less than 1 per cent) and a "left-shifted" oxygen-hemoglobin dissociation curve (mean P50, 21.6 +/- 2.3 [+/- S.D.] torr; normal, 26.7 +/- 1.1).
J R, Smith, S A, Landaw
openaire +4 more sources
Twenty-two smokers with elevated hematocrits (mean, 54 per cent) had elevated blood carboxyhemoglobin (mean, 11.6 per cent; normal, less than 1 per cent) and a "left-shifted" oxygen-hemoglobin dissociation curve (mean P50, 21.6 +/- 2.3 [+/- S.D.] torr; normal, 26.7 +/- 1.1).
J R, Smith, S A, Landaw
openaire +4 more sources
Hematology/Oncology Clinics of North America, 2003
The differential diagnosis of an elevated hematocrit and the criteria for the diagnosis of polycythemia vera present little or no problem; however, there is not a consensus on therapy. Spivak likened this to a conundrum--"an intricate and difficult problem." Nonetheless, it can be argued that on the basis of the following criteria--life expectancy, the
Nathanial, Berlin, Nathanial I, Berlin
openaire +2 more sources
The differential diagnosis of an elevated hematocrit and the criteria for the diagnosis of polycythemia vera present little or no problem; however, there is not a consensus on therapy. Spivak likened this to a conundrum--"an intricate and difficult problem." Nonetheless, it can be argued that on the basis of the following criteria--life expectancy, the
Nathanial, Berlin, Nathanial I, Berlin
openaire +2 more sources
Pediatrics, 1982
The article by Ramamurthy and Brans (Pediatrics 68:168, 1981) on the criteria for diagnosis and treatment of neonatal polycythemia was most interesting. Their conclusions that there are considerable and unpredictable differences between capillary, peripheral, venous, and umbilical venous hematocrit levels in the same neonate might be of much importance
M, Shohat, P, Merlob, S H, Reisner
openaire +2 more sources
The article by Ramamurthy and Brans (Pediatrics 68:168, 1981) on the criteria for diagnosis and treatment of neonatal polycythemia was most interesting. Their conclusions that there are considerable and unpredictable differences between capillary, peripheral, venous, and umbilical venous hematocrit levels in the same neonate might be of much importance
M, Shohat, P, Merlob, S H, Reisner
openaire +2 more sources
The Indian Journal of Pediatrics, 1997
461 consecutive inborn babies, delivered during the period September 1993-March 1994 were subjected to a microhematocrit assessment at 6 hours of age to determine the incidence of polycythemia. 47 babies (inborn and out born), admitted to the neonatal unit with confirmed polycythemia were studied for clinical and laboratory abnormalities.
L, Krishnan, A, Rahim
openaire +2 more sources
461 consecutive inborn babies, delivered during the period September 1993-March 1994 were subjected to a microhematocrit assessment at 6 hours of age to determine the incidence of polycythemia. 47 babies (inborn and out born), admitted to the neonatal unit with confirmed polycythemia were studied for clinical and laboratory abnormalities.
L, Krishnan, A, Rahim
openaire +2 more sources
Internal and Emergency Medicine, 2010
The diagnostic approach to a patient with polycythemia has been greatly simplified by the introduction of new genetic testing in addition to traditional tests, such as measurement of red cell mass and serum erythropoietin (Epo) level. Clonal erythrocytosis, which is the diagnostic feature of polycythemia vera (PV), is almost always associated with a ...
Raffaele, Landolfi +3 more
openaire +2 more sources
The diagnostic approach to a patient with polycythemia has been greatly simplified by the introduction of new genetic testing in addition to traditional tests, such as measurement of red cell mass and serum erythropoietin (Epo) level. Clonal erythrocytosis, which is the diagnostic feature of polycythemia vera (PV), is almost always associated with a ...
Raffaele, Landolfi +3 more
openaire +2 more sources
Current Treatment Options in Oncology, 2018
Polycythemia vera (PV) is the most common myeloproliferative neoplasm (MPN), the ultimate phenotype of the JAK2 V1617F mutation, the MPN with the highest incidence of thromboembolic complications, which usually occur early in the course of the disease, and the only MPN in which erythrocytosis occurs. The classical presentation of PV is characterized by
openaire +2 more sources
Polycythemia vera (PV) is the most common myeloproliferative neoplasm (MPN), the ultimate phenotype of the JAK2 V1617F mutation, the MPN with the highest incidence of thromboembolic complications, which usually occur early in the course of the disease, and the only MPN in which erythrocytosis occurs. The classical presentation of PV is characterized by
openaire +2 more sources
Seminars in Oncology Nursing, 1996
To review the proliferative nature of polycythemia vera (PV), clinical features, laboratory findings, treatment options and controversies, and nursing management.Textbook chapters and review articles that pertain to polycythemia vera.Polycythemia vera is a chronic myeloproliferative disorder that can evolve into acute leukemia.
openaire +2 more sources
To review the proliferative nature of polycythemia vera (PV), clinical features, laboratory findings, treatment options and controversies, and nursing management.Textbook chapters and review articles that pertain to polycythemia vera.Polycythemia vera is a chronic myeloproliferative disorder that can evolve into acute leukemia.
openaire +2 more sources
Disease-a-Month, 1992
Polycythemia vera (PV) is one of the myeloproliferative diseases, and, as such, is an example of clonal hematopoiesis. The progeny of a single, abnormal, hematopoietic stem cell gain a growth advantage over their normal counterparts resulting in overproduction of red cells generally accompanied by overproduction of granulocytes and platelets as well ...
openaire +2 more sources
Polycythemia vera (PV) is one of the myeloproliferative diseases, and, as such, is an example of clonal hematopoiesis. The progeny of a single, abnormal, hematopoietic stem cell gain a growth advantage over their normal counterparts resulting in overproduction of red cells generally accompanied by overproduction of granulocytes and platelets as well ...
openaire +2 more sources